Sivan M Bokobza
Overview
Explore the profile of Sivan M Bokobza including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
159
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jiang Y, Verbiest T, Devery A, Bokobza S, Weber A, Leszczynska K, et al.
Int J Radiat Oncol Biol Phys
. 2016 Mar;
95(2):772-81.
PMID: 27020103
Purpose: Poly(ADP-ribose) polymerase (PARP) inhibitors potentiate radiation therapy in preclinical models of human non-small cell lung cancer (NSCLC) and other types of cancer. However, the mechanisms underlying radiosensitization in vivo...
2.
Jiang Y, Allen D, Kersemans V, Devery A, Bokobza S, Smart S, et al.
Lung Cancer
. 2015 Sep;
90(2):191-8.
PMID: 26323213
Objectives: Tumours can be categorised based on their stromal architecture into tumour vessel and stromal vessel phenotypes, and the phenotypes have been suggested to define tumour response to chronic treatment...
3.
Devery A, Wadekar R, Bokobza S, Weber A, Jiang Y, Ryan A
Int J Oncol
. 2015 Jul;
47(3):849-56.
PMID: 26179332
Vascular endothelial growth factor (VEGF) is a key stimulator of physiological and pathological angiogenesis. VEGF signals primarily through VEGF receptor 2 (VEGFR2), a receptor tyrosine kinase whose expression is found...
4.
Bokobza S, Jiang Y, Weber A, Devery A, Ryan A
Oncotarget
. 2014 Jun;
5(13):4765-78.
PMID: 24946858
Although non-small cell lung cancer (NSCLC) patients with EGFR mutation positive (EGFR M+) tumors initially respond well to EGFR tyrosine kinase inhibitor (TKI) monotherapy, the responses are usually incomplete. In...
5.
Bokobza S, Jiang Y, Weber A, Devery A, Ryan A
Int J Radiat Oncol Biol Phys
. 2014 Mar;
88(4):947-54.
PMID: 24606853
Purpose: To evaluate the combination of radiation and an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) in preclinical models of human non-small cell lung cancer. Methods And Materials:...
6.
Bokobza S, Ye L, Kynaston H, Jiang W
Mol Cell Biochem
. 2010 Dec;
349(1-2):33-40.
PMID: 21116689
The role of bone morphogenetic proteins in the progression and metastasis of prostate cancer is a topic that has undergone extensive research. This study investigates the role of BMP member...
7.
Bokobza S, Ye L, Kynaston H, Jiang W
Oncol Rep
. 2010 Nov;
24(6):1653-9.
PMID: 21042764
The majority of advanced prostate cancers metastasis to the bone. Mediators of bone remodelling, the bone morphogenetic proteins have extensively been implicated in the progression and metastasis of prostate cancer....
8.
Bokobza S, Ye L, Kynaston H, Jiang W
J Cell Physiol
. 2010 May;
225(2):529-36.
PMID: 20458753
Bone morphogenetic proteins (BMPs) have long been implicated in the process of prostate cancer progression and bone metastasis. This current study investigates the role of GDF-9, a BMP member, in...
9.
Ye L, Bokobza S, Jiang W
Int J Mol Med
. 2009 Sep;
24(5):591-7.
PMID: 19787192
Bone morphogenetic proteins (BMPs) belong to the TGF-beta superfamily, which plays important roles in foetal and postnatal development and also maintains the homeostasis of various tissues and organs. Due to...
10.
Bokobza S, Ye L, Kynaston H, Mansel R, Jiang W
Cancer Genomics Proteomics
. 2009 May;
6(2):101-8.
PMID: 19451094
Background: Breast cancer is the leading female cancer in the UK. Recent work has shown that Bone Morphogenetic Proteins (BMPs) and their receptors may be involved in the progression of...